Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (31-40 of 220) with videos related to

Pageof 22
Sort By:
Hepatology (Baltimore, Md.)|February 4, 2005
HCV persistence: cure is still a four letter wordJordan J Feld, T Jake Liang
The New England Journal of Medicine|May 6, 2014
Therapy of hepatitis C--back to the futureT Jake Liang, Marc G Ghany
Gastroenterology|December 3, 2014
Building bridges and providing transparency to the hepatitis C virus drug approval processMarc G Ghany, T Jake Liang
Gastroenterology|January 10, 2021
SARS-CoV-2 Infection in the Gastrointestinal Tract: Fecal-Oral Route of Transmission for COVID-19?Xiang-Jin Meng, T Jake Liang
Viruses|July 29, 2023
Hepatitis Delta Virus-Host Protein Interactions: From Entry to EgressSusannah Stephenson-Tsoris, T Jake Liang
The New England Journal of Medicine|August 16, 2013
Current and future therapies for hepatitis C virus infectionMarc G Ghany, T Jake Liang
Hepatology (Baltimore, Md.)|February 1, 2006
Hepatitis C -- identifying patients with progressive liver injuryJordan J Feld, T Jake Liang
ACS Infectious Diseases|September 13, 2016
Border Control in Hepatitis C Virus Infection: Inhibiting Viral EntryCameron J Schweitzer, T Jake Liang
Current Opinion in Virology|July 10, 2013
Impact of host and virus genome variability on HCV replication and response to interferonCameron J Schweitzer, T Jake Liang
The New England Journal of Medicine|March 31, 2018
Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid EpidemicT Jake Liang, John W Ward
Pageof 22

Showing results (31-40 of 220) with videos related to

Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|February 4, 2005
HCV persistence: cure is still a four letter wordJordan J Feld, T Jake Liang
The New England Journal of Medicine|May 6, 2014
Therapy of hepatitis C--back to the futureT Jake Liang, Marc G Ghany
Gastroenterology|December 3, 2014
Building bridges and providing transparency to the hepatitis C virus drug approval processMarc G Ghany, T Jake Liang
Gastroenterology|January 10, 2021
SARS-CoV-2 Infection in the Gastrointestinal Tract: Fecal-Oral Route of Transmission for COVID-19?Xiang-Jin Meng, T Jake Liang
Viruses|July 29, 2023
Hepatitis Delta Virus-Host Protein Interactions: From Entry to EgressSusannah Stephenson-Tsoris, T Jake Liang
The New England Journal of Medicine|August 16, 2013
Current and future therapies for hepatitis C virus infectionMarc G Ghany, T Jake Liang
Hepatology (Baltimore, Md.)|February 1, 2006
Hepatitis C -- identifying patients with progressive liver injuryJordan J Feld, T Jake Liang
ACS Infectious Diseases|September 13, 2016
Border Control in Hepatitis C Virus Infection: Inhibiting Viral EntryCameron J Schweitzer, T Jake Liang
Current Opinion in Virology|July 10, 2013
Impact of host and virus genome variability on HCV replication and response to interferonCameron J Schweitzer, T Jake Liang
The New England Journal of Medicine|March 31, 2018
Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid EpidemicT Jake Liang, John W Ward
Pageof 22